Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anthony Fenton"'
Autor:
Rajkumar Chinnadurai, Latha Gullapudi, Anthony Fenton, Charles J. Ferro, James Ritchie, Indranil Dasgupta, Maarten W. Taal, Paul Cockwell, Petros Kampanis, Stephen Harding, Philip A. Kalra
Publikováno v:
PLoS Medicine
PLoS Medicine, Vol 17, Iss 2, p e1003050 (2020)
PLoS Medicine, Vol 17, Iss 2, p e1003050 (2020)
Background In studies including the general population, the presence of non-malignant monoclonal gammopathy (MG) can be causally associated with kidney damage and shorter survival. We assessed whether the presence of an MG is associated with a higher
Publikováno v:
BMC Nephrology, Vol 19, Iss 1, Pp 1-8 (2018)
BMC Nephrology
BMC Nephrology
Background Minimal change disease (MCD) is a common cause of the nephrotic syndrome in adults with limited evidence on its treatment and prognosis. We examined the presenting characteristics, treatments, and outcomes of adult patients with MCD in our
Autor:
Mark Jesky, Federica Genovese, Daniel Guldager Kring Rasmussen, Anthony Fenton, Charles J. Ferro, Morten A. Karsdal, Paul Cockwell
Publikováno v:
Clinical Kidney Journal
Background Tubulointerstitial fibrosis is a major pathological feature in chronic kidney disease (CKD) and collagen type III (COL3) is a major component of the renal fibrotic scar. We hypothesized that a dysregulated turnover of COL3 is an important
Autor:
Paula F. Orlandi, Jing Huang, Masafumi Fukagawa, Wendy Hoy, Vivekanand Jha, Kook-Hwan Oh, Laura Sola, Paul Cockwell, Adeera Levin, Harold I. Feldman, Wendy E. Hoy, Zaimin Wang, Jianzhen Zhang, Helen G. Healy, Anthony Fenton, Lisa Nessel, Alan Go, Lawrence Appel, Curie Ahn, Dong Wan Chae, Seung Hyeok Han, Ognjenka Djurdjev, Mila Tang, Pablo G. Rios, Liliana Gadola, Takayuki Hamano, Naohiko Fujii, Takahiro Imaizumi, Ashok Kumar Yadav, Vivek Kumar
Rates of chronic kidney disease (CKD) progression, end stage kidney disease (ESKD), all-cause mortality, and cardiovascular (CVD) events among individuals with CKD vary widely across countries. Well-characterized demographic, comorbidity, and laborat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69bb14bbb337df8962d975cca13acce9
https://ora.ox.ac.uk/objects/uuid:35be067f-c0d8-45f6-bde8-ec3f3573d973
https://ora.ox.ac.uk/objects/uuid:35be067f-c0d8-45f6-bde8-ec3f3573d973
Autor:
Maarten W. Taal, Scott Harris, Ziad A. Massy, A. Burmeister, Philip A. Kalra, Martin J Landray, Jonathan Emberson, S Liabeuf, Colin A. Hutchison, Fraser Sds., Paul Cockwell, Anthony Fenton, A Shardlow, James Ritchie
ObjectiveTo clarify the associations between polyclonal serum free light chain (sFLC) levels and adverse outcomes in patients with chronic kidney disease (CKD) by conducting a systematic review and individual patient data meta-analyses.Patients and M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9be9c05889d3cb004d73faff2c8687a
https://eprints.soton.ac.uk/413664/
https://eprints.soton.ac.uk/413664/
Autor:
Stephen Harding, Mark Jesky, Anthony Fenton, Charles J. Ferro, Indranil Dasgupta, Punit Yadav, Tim Plant, Miguel Ndumbo, Mark T. Drayson, Katerina McCann, Stephanie Stringer, Frank A. Redegeld, Paul Cockwell, Khai Ping Ng
Publikováno v:
European journal of clinical investigation. 46(5)
BACKGROUND Mast cell activation can lead to nonclassical activation of the Renin-Angiotensin-Aldosterone System. However, the relevance of this to human chronic kidney disease is unknown. We assessed the association between serum tryptase, a product